Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Trend: Pharma industry warming up to digital therapeutics

– Som­ryst app by Pear Ther­a­peu­tics

Dig­i­tal ther­a­peu­tics have poten­tial but com­mer­cial suc­cess unproven (Van­tage):

Devel­op­ing drugs to treat dis­or­ders of the cen­tral ner­vous sys­tem is famous­ly fraught with dif­fi­cul­ty. Sev­er­al com­pa­nies, includ­ing Pear Ther­a­peu­tics and Dthera, are tak­ing a wild­ly dif­fer­ent approach: dig­i­tal ther­a­peu­tics. These are pieces of soft­ware designed to treat dis­ease that are reg­u­lat­ed, pre­scribed and even paid for as if they were drugs … Pear is so far the only com­pa­ny to have brought a dig­i­tal ther­a­peu­tic to mar­ket – but it is by no means the only com­pa­ny in this space. Akili Inter­ac­tive has­filed for FDA approval of AKL-T01, a com­put­er game designed to treat ADHD, and anoth­er prod­uct, AKL-T02, is in late-stage devel­op­ment for cog­ni­tive dys­func­tion in chil­dren with autism spec­trum dis­or­der.

And Akili, like Pear, has received gen­er­ous finan­cial back­ing from ven­ture investors. Akili raised $68m in a series C round last year from investors includ­ing Mer­ck Ven­tures and Temasek, Singapore’s Nation­al Wealth Fund. Pear’s $64m series C, also involv­ing Temasek with oth­er back­ers includ­ing Novar­tis, was one of this year’s biggest.

Click Ther­a­peu­tics, which makes apps for var­i­ous neu­ro­log­i­cal con­di­tions and has part­nered with Otsu­ka on the devel­op­ment and sale of its depres­sion ther­a­peu­tic CT-152, counts Sanofi and Hik­ma Phar­ma­ceu­ti­cals among its investors.

Per­haps drug com­pa­nies see the devel­op­ment of dig­i­tal prod­ucts as a way of wring­ing some kind of finan­cial reward out of CNS dis­or­ders giv­en the dif­fi­cul­ty of devel­op­ing drugs in this area.”

News in Context:

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness, Technology

Tags: , , , , , , ,

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)